Search company, investor...
Adviso company logo


About Adviso

Adviso helps companies solve complex issues by offering services and solutions in strategy and digital marketing. It is based in Montreal, Quebec.

Headquarters Location

4388, rue Saint-Denis Suite 300

Montreal, Quebec, H2J 2L1,


Missing: Adviso's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Adviso's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Latest Adviso News

18:00 EDT Oncology Expert, Dr. Nathan Pennell of the Cleveland Clinic Taussig Cancer Institute, Joins Vial's Oncology CRO Adviso...

Nov 1, 2022

News provided by Share this article Share this article SAN FRANCISCO, Nov. 1, 2022 /PRNewswire/ -- Dr. Nathan Pennell of the Cleveland Clinic Taussig Cancer Institute has joined Vial's Oncology CRO Advisory Board. Dr. Pennell will advise Vial on enhancing its Oncology CRO product and services. Nathan Pennell, MD, Ph.D., FASCO, is a Professor of Medicine and the Director of the Lung Cancer Medical Oncology Program at the Cleveland Clinic Taussig Cancer Institute. Dr. Pennell was granted his Ph.D. in Neuroscience and MD from the University of Florida, College of Medicine in Gainesville. He completed his residency in Internal Medicine at Brigham and Women's Hospital and then did his fellowship training at the Dana Farber Cancer Institute. Dr. Pennell specializes in the care of patients with thoracic malignancies. His clinical research interests are centered around developing novel cancer therapies, and he has contributed to 280+ publications. Dr. Pennell is the Editor-in-Chief of the ASCO Educational Book, podcast editor for the Journal of Oncology Practice, and on the editorial board for JAMA Oncology. Dr. Pennell also serves as the Deputy Associate Director for Clinical Research, at Case Comprehensive Cancer Center. "Vial has an ambitious mission to enhance clinical trial processes through technology. The technology they are creating could improve trial efficiency, accelerating the process for treatments to reach the market sooner. I am delighted to serve as an advisor for their Oncology CRO with the goal of helping cancer patients receive treatments sooner," said Dr. Pennell on joining Vial's scientific advisory board. Vial is a tech-enabled CRO providing cutting-edge clinical trial management services that deliver faster, more efficient trials for biotech sponsors. The Vial Oncology CRO distinguishes itself by leveraging digital technology, such as its Vial Technology Platform, which brings together eSource , EDC , eTMF , and ePro , in one connected system to streamline site processes. These best-in-class CRO services will accelerate the development of new therapies and devices for oncology sponsors and patients. See the full release here . About Vial: Vial is a tech-enabled, next-generation CRO that promises faster and higher-quality execution of trials. The Vial Contract Research Organization (CRO) delivers on the promise of more efficient trials through its innovative technology platform that powers trials end-to-end. Vial operates across multiple therapeutic areas ( Dermatology CRO , Ophthalmology CRO , Oncology CRO , Gastroenterology CRO , and Neurology CRO ). Vial is a San Francisco, California-based company. SOURCE Vial

Adviso Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Adviso Rank

Adviso Frequently Asked Questions (FAQ)

  • Where is Adviso's headquarters?

    Adviso's headquarters is located at 4388, rue Saint-Denis, Montreal.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.